ARCHIVES

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995

Genomic Tests Not Shown To Decrease Deaths, Improve Quality Of Life

October 27, 2006

WHI community Prevention Study Concept Approved

November 19, 1993

In Brief: NCCR Presents Gold Medal To Sen. Karkin; DCT Recruits Okunieff For Radiation Oncology

February 26, 1993

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012